Skip to main content

lung cancer Archives

Cancer patient chooses Nashville for VICC care and the Nashville Predators

Jun. 13, 2017—Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center.

Read more


Team’s discovery offers new insight on lung cancer risk

Jan. 12, 2017—Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

Read more


VICC trial putting lung cancer therapy to the test

Oct. 20, 2016—Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.

Read more


VUMC’s Lehman lands LUNGevity research support

Sep. 22, 2016—Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research.

Read more


VUMC Lung Cancer Screening Center earns recognition

Jun. 9, 2016—Vanderbilt University Medical Center has been designated a Lung Cancer Screening Center by the American College of Radiology.

Read more


Overcoming lung cancer drug resistance

Feb. 10, 2016—Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.

Read more


Study identifies new culprit in lung cancer development

Jan. 27, 2016—A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.

Read more


Lovly lands cancer research grant from V Foundation

Jan. 21, 2016—Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.

Read more


VICC helps expand cancer patient’s treatment options

Jan. 14, 2016—Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have.

Read more


VICC’s Horn lands Team Leadership Award from NCI

Nov. 19, 2015—Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI).

Read more


Potential target for lung cancer therapy

Oct. 5, 2015—The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.

Read more


Singer’s selfless gift benefits lung cancer program

Jul. 30, 2015—In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special.

Read more


Page 2 of 512345

Upcoming Events

25 September
12:00 PM

27 September
10:00 AM

MORE EVENTS »